Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiori... by Behringer, Karolin, MD, Goergen, Helen, Dipl Math, Hitz, Felicitas, MD, Zijlstra, Josée M, MD, Greil, Richard, MD, Markova, Jana, MD, Sasse, Stephanie, MD, Fuchs, Michael, MD, Topp, Max S, MD, Soekler, Martin, MD, Mathas, Stephan, MD, Meissner, Julia, MD, Wilhelm, Martin, MD, Koch, Peter, MD, Lindemann, Hans-Walter, MD, Schalk, Enrico, MD, Semrau, Robert, MD, Kriz, Jan, MD, Vieler, Tom, MD, Bentz, Martin, MD, Lange, Elisabeth, MD, Mahlberg, Rolf, MD, Hassler, Andre, MD, Vogelhuber, Martin, MD, Hahn, Dennis, MD, Mezger, Jörg, MD, Krause, Stefan W, MD, Skoetz, Nicole, MD, Böll, Boris, MD, von Tresckow, Bastian, MD, Diehl, Volker, MD, Hallek, Michael, MD, Borchmann, Peter, MD, Stein, Harald, MD, Eich, Hans, MD, Engert, Andreas, Dr

Get full text

Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia (ALL) Achieving Remission with Blinatumomab by Stein, Anthony S., MD, Topp, Max S., MD, Gokbuget, Nicola, MD, Bargou, Ralf C., MD, Dombret, Hervé, MD, PhD, Larson, Richard A., MD, Rambaldi, Alessandro, MD, Schiller, Gary J., MD, Zugmaier, Gerhard, MD, Sterling, Lulu, PhD, Benjamin, Jonathan, MD, PhD, Kantarjian, Hagop, MD, Forman, Stephen J., MD

Get full text

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study by Topp, Max S, Dr, Gökbuget, Nicola, MD, Stein, Anthony S, MD, Zugmaier, Gerhard, MD, O'Brien, Susan, MD, Bargou, Ralf C, Prof, Dombret, Hervé, MD, Fielding, Adele K, PhD, Heffner, Leonard, MD, Larson, Richard A, Prof, Neumann, Svenja, MD, Foà, Robin, MD, Litzow, Mark, Prof, Ribera, Josep-Maria, Prof, Rambaldi, Alessandro, MD, Schiller, Gary, MD, Brüggemann, Monika, MD, Horst, Heinz A, MD, Holland, Chris, MS, Jia, Catherine, PhD, Maniar, Tapan, MD, Huber, Birgit, PhD, Nagorsen, Dirk, MD, Forman, Stephen J, MD, Kantarjian, Hagop M, Prof

Get full text

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial by Engert, Andreas, MD, Haverkamp, Heinz, PhD, Kobe, Carsten, MD, Markova, Jana, MD, Renner, Christoph, MD, Ho, Antony, MD, Zijlstra, Josée, MD, Král, Zdenek, MD, Fuchs, Michael, MD, Hallek, Michael, MD, Kanz, Lothar, MD, Döhner, Hartmut, MD, Dörken, Bernd, MD, Engel, Nicole, MD, Topp, Max, MD, Klutmann, Susanne, MD, Amthauer, Holger, MD, Bockisch, Andreas, MD, Kluge, Regine, MD, Kratochwil, Clemens, MD, Schober, Otmar, MD, Greil, Richard, MD, Andreesen, Reinhard, MD, Kneba, Michael, MD, Pfreundschuh, Michael, MD, Stein, Harald, MD, Eich, Hans Theodor, MD, Müller, Rolf-Peter, MD, Dietlein, Markus, MD, Borchmann, Peter, MD, Diehl, Volker, MD

Get full text